Carmona-Sánchez R, Álvarez TF

Language: Spanish
References: 25
Page: 393-398
PDF size: 44.34 Kb.

ABSTRACT

Introduction: The prevalence of use of complementary and alternative medicine (CAM) is high in developed countries and is believed to be even higher in developing countries. There are no data on the use of CAM in patients with gastrointestinal tract disorders in Mexico. Objective: To determine the prevalence of CAM use in Mexican patients with gastrointestinal disorders. Material and methods: A survey was applied to all first-time patients presenting at the gastroenterology service between December 2003 and November 2004. Patients with irritable bowel syndrome (IBS, defined by Rome II), functional dyspepsia (FD, defined by Rome II), and gastroesophageal reflux disease (GERD, defined as erosive esophagitis or abnormal pH intraesophageal monitoring) were included. The use of CAM to relieve gastrointestinal symptoms was examined and the demographic data, the disease history and healthcare use 12 months prior to the study were recorded. Results: The survey was answered by 413 patients (61% IBS, 22% FD y 17% GERD). A total of 181 users of CAM were identified (44% of the total group). The use of CAM was most frequent for IBS (51% IBS, 36% FD, 27% GERD). Herbal medicine was the type of CAM most often used by all groups. The factors associated with CAM use were IBS, history of abdominal surgery, emergency room visits, disabilities and prescription of benzodiazepines, and ≥ 3 medical visits for gastrointestinal tract disorders within the previous year. Conclusions: Prevalence of CAM use is high in general and significantly higher for IBS. Herbal medicine is the most frequently used modality.

REFERENCES

1. Langmead L, Ramptom DS. Review article: herbal treatment in gastrointestinal and liver disease – benefits and dangers. Aliment Pharmacol Ther 2001; 15: 1239-52.

2. Koretz RL, Rotblatt M. Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly. Clin Gastroenterol Hepatol 2004; 2: 957-67.

3. Palinkas LA, Kabongo ML. The use of complementary and alternative medicine by primary care patients. J Fam Pract 2000; 49: 1121-30.

4. Zollman C, Vickers A. ABC of complementary medicine. Users and practitioners of complementary medicine. Br Med J 1999; 319: 838-8.

5. Bodeker G. Lessons on integration from the developing world’s experience. Br Med J 2001; 322: 164-7.

6. Linde K, Ter Riet G, Hondras M, Vickers A, Saller R, Melchart D. Systematic rewiews of complementary therapies – an annotated bibliography. Part 2: herbal medicine. BMC Complement Altern Med 2001; 1: 5.

7. Langmead L, Feakins RM, Goldthorpe S, et al. Randomized, double-blind, placebo controlled trial of oral aloe vera gel for ulcerative colitis. Aliment Pharmacol Ther 2004; 19: 739-47.

8. Ouyang H, Chen JDZ. Review article: therapeutic roles of acupunture in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20: 831-41.

9. Lee H, Ernest E. Acupunture for GI endoscopy: a systematic review. Gastrointest Endosc 2004; 60: 784-89.

10. Drossman DA, Coranzziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II The functional gastrointestinal disorders. 2nd ed. USA: Degnon Associates; 2000.

11. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.

12. Dent J, Brun F, Fendrick AM, Fennnerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999; 44(Suppl. 2): S1-S16.

13. Richter JE, Bradley LA, DeMeester TR. Normal 24-hour ambulatory esophageal pH values: influence of study center, pH electrode, age and gender. Dig Dis Sci 1992; 37: 849-56.

14. Whitehead WE, Palsson A, Jones KR. Systematic review of the commorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.

15. North CS, Downs D, Clouse RE, et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2: 787-95.

16. Stickel F, Hoehn B, Schuppan D, Seitz HK. Review article: nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 2003; 18: 357-73.

17. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-75.

18. Sutherland RL, Verhoef MJ. Why do patients seek a second opinion or alternative medicine? J Clin Gastroenterol 1994; 19: 194-7.

19. Smart HL, Mayberry JF, Atkinson M. Alternative medicine consultations and remedies in patients with irritable bowel syndrome. Gut 1986; 28: 826-8.

20. Rawsthorne P, Shanahan F, Cronin NC, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1298-303.

21. Moody GA, Eaden JA, Bhakta P, Sher K, Mayberry JF. The role of complementary medicine in European and Asian patients with inflammatory bowel disease. Public Health 1998; 93: 697-701.

22. Hilsden RJ, Scott CM, Verhoef MJ. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 1998; 93: 697-701.

23. Langmead L, Chitnis M, Rampton DS. Complementary therapies in GI patients: who uses them and why? Gut 2000; 46(Suppl. 2): A22.

24. Struthers R, Nichols LA. Utilization of complementary and alternative medicine among racial and ethnic minority populations: implications for reducing health disparities. Annu Rev Nurs Res 2004; 22: 285-313.

25. Pittler MH, Ernest E. Systematic review: hepatotoxic events associated with herbal medicine products. Aliment Pharmacol Ther 2003; 18: 451-71.